Collaboration

#Cancer research #Cancer Research Horizons #Cancer Research UK #Collaboration #Guardant Health #Precision medicine

CRUK and Guardant collaborate on precision cancer drugs

Cancer Research UK (CRUK), Cancer Research Horizons, and precision oncology company Guardant Health have launched a collaboration to advance cancer treatment. The agreement will enable the parties to discuss opportunities for collaboration to support the charity’s research and clinical development activities, focusing primarily on its clinical trials run by its… Read More

#Business & Investment #Cancer Research #News

#Awards #CN Bio #Collaboration #FDA #OBN Awards #Organ-on-a-chip

CN Bio named winner with most impactful industry collaboration  

CN Bio, an organ-on-a-chip (OOC) company that designs and manufactures single-and multi-organ microphysiological systems (MPS), has received the ‘Most Impactful Industry Collaboration of the Year’ at the 2023 OBN Awards.   The award recognises the ongoing success of the company’s collaboration with the US Food and Drug Administration… Read More

#News

Scientist in laboratory
#Cancer research #Cancer Research UK #Collaboration #KWF Dutch Cancer Society #Oncology

UK-Dutch alliance to strengthen early clinical oncology research

Cancer Research UK and the KWF Dutch Cancer Society (KWF) have announced a new multi-project strategic partnership to advance promising therapeutic agents for cancer. Under the partnership, KWF intends to provide funding to enable the development of select early phase clinical programmes through Cancer Research UK’s Centre… Read More

#Cancer Research #News

Hospital patient on ventilator
#Biomarkers #Collaboration #Covid-19 #GeNeuro #Long Covid #Personalised medicine #Verily

Partners take a personalised approach to long Covid

GeNeuro and Verily will work together to investigate biomarkers related to activation of the proinflammatory HERV-W envelope protein (W-ENV) in SARS-CoV-2 infection. Through this collaboration, the companies will build on results published earlier this year, which evidenced the in vitro activation of HERV-W by SARS-CoV-2 in… Read More

#Editor's Choice #News

#AI #BioMap #Biotherapeutics #Collaboration #Sanofi

Collaboration to develop AI modules for biotherapeutics 

BioMap has entered a strategic collaboration with Sanofi to co-develop AI modules for biotherapeutic drug discovery, leveraging BioMap’s AI platform.  Traditional AI methods require vast amounts of labeled data to make accurate predictions. However, in life science, labeled data are often in short supply. BioMap’s foundational models… Read More

#News

Structure of the eye
#AMD #Boehringer Ingelheim #CDR-Life #Collaboration #Geographic atrophy #Ophthalmology #Phase I trial

Antibody treatment for geographic atrophy enters clinical trials

Collaborators Boehringer Ingelheim and CDR-Life have commenced a Phase I evaluation of BI 771716, their antibody fragment-based treatment developed to preserve the vision of people with geographic atrophy (GA). Boehringer Ingelheim and CDR-Life entered a licensing agreement in May 2020 and announced the… Read More

#Editor's Choice #News

Research laboratory
#Cancer research #Collaboration #Merck #Oncology #The Institute of Cancer Research

ICR and Merck renew cancer drug discovery alliance

Merck and The Institute of Cancer Research (ICR), London, UK, have renewed their strategic alliance in the discovery and development of new cancer drugs. Scientists in the Centre for Cancer Drug Discovery at the ICR will work with researchers at Merck to discover and develop new… Read More

#Cancer Research #News

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Latest Guide: Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this new guide from SGS… Read More

#News

#CDMO #Collaboration #CRO #Drug development #Drug discovery #Guide

Streamline your drug development pathway

In pharmaceutical development, collaborating with multiple Contract Development and Manufacturing Organisations (CDMOs) and Contract Research Organisations (CROs) poses potential hurdles – from poor communication to delays, errors, and inconsistent feedback during the progression from preclinical to formulation optimisation and clinical trials. Download this SGS guide to discover: How to collaborate… Read More

#Intelligence #Resources

3d structure of the protein molecule
#Collaboration #Genetics / genomics #Partnership #Proteomics #Structural Genomics Consortium #X-Chem

Partners collaborate to unlock the human proteome

X-Chem and the Structural Genomics Consortium (SGC) have entered a collaboration aimed at creating new chemical tools to study human proteins. The goal is to generate DNA-encoded library (DEL) screening data for large numbers of under-addressed proteins in the human proteome – ultimately allowing drug discovery and machine learning (ML)… Read More

#Business & Investment #News

#Collaboration #Ginkgo Bioworks #Pfizer #RNA

Pfizer does $331 million deal with Ginkgo Bioworks

Ginkgo Bioworks has announced a collaboration with Pfizer focused on the discovery of RNA-based drug candidates.   In the collaboration, Pfizer will leverage Ginkgo's proprietary RNA technology to advance the discovery and development of novel RNA molecules across priority research areas. Ginkgo will receive an upfront payment and is eligible to… Read More

#Business & Investment #News

Protein
#Biomarkers #Clinical trials #Collaboration #Eurofins Genomics #Olink #Partnership #Precision medicine #Proteomics

Eurofins Genomics and Olink partner to advance proteomics research

Eurofins Genomics has adopted Olink technology to advance proteomics research and accelerate its precision medicine programmes. The collaboration is designed to bolster the company’s offerings in the fields of research, population health, and regulated clinical trials. Olink Explore HT is the company's latest solution for high-throughput proteomics, allowing scientists to… Read More

#Business & Investment #News

Cancer cells
#Bispecific therapeutics #Cancer research #Collaboration #Drug development #Immatics #Moderna #mRNA

Multi-platform collab to develop innovative oncology therapeutics 

Moderna and Immatics have announced a strategic research and development collaboration to pioneer novel and transformative therapies for cancer patients with high, unmet medical need.   This broad multi-platform collaboration will leverage the scientific expertise and core operational capabilities of both companies, combining Immatics’ TCR platform with Moderna’s… Read More

#Cancer Research #News

Antibodies
#Antibodies #Autoimmune disease #Collaboration #Ono Pharmaceutical #Twist Bioscience

Partners to discover antibodies for autoimmune diseases

Twist Bioscience and Ono Pharmaceutical will combine their efforts to discover and develop novel antibodies for the treatment of autoimmune diseases. Under the terms of the agreement, Twist will use its ‘Library of Libraries’ to conduct research activities to discover novel antibodies against targets identified by Ono. Twist also recently… Read More

#Business & Investment #News

#Collaboration #Drug development #Drug discovery #Horizon Europe #Mergers and acquisitions #Partnership

New: DDW Highlights 11 September 2023

The latest episode of the DDW Highlights podcast is now available to listen to below. DDW’s Megan Thomas narrates five key stories of the week to keep DDW subscribers up-to-date on the latest industry updates.  This week we have seen the vital importance of collaboration to the… Read More

#News

#Collaboration #Drug development #Drug discovery #Horizon Europe #Mergers and acquisitions #Partnership

This week in drug discovery (4-8 September)  

News round-up for 4-8 September by DDW Digital Content Editor Diana Spencer. This week we have seen the vital importance of collaboration to the successful development and discovery of novel therapeutics, exemplified by the new deal agreed by the UK and EU to admit the UK… Read More

#News